2005
DOI: 10.1016/j.biomaterials.2005.02.023
|View full text |Cite
|
Sign up to set email alerts
|

Bioactivation of an anorganic bone matrix by P-15 peptide for the promotion of early bone formation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
49
0
2

Year Published

2007
2007
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(59 citation statements)
references
References 37 publications
4
49
0
2
Order By: Relevance
“…Furthermore, the 9.0 ± 7.3% of residual ABM/P-15 revealed by histomorphometry may have continued to form new bone in vivo and added to the percentage of new bone formation, thus making the difference between the mean scores of the treatments even smaller with additional time (Table 3). The successful bone formation results achieved in this study with ABM/P-15 are consistent with results obtained in other preclinical models [14][15][16], dental models [17][18][19][20][21][22][23][24][25][26], and the pilot orthopaedic model [9].…”
Section: Discussionsupporting
confidence: 89%
See 2 more Smart Citations
“…Furthermore, the 9.0 ± 7.3% of residual ABM/P-15 revealed by histomorphometry may have continued to form new bone in vivo and added to the percentage of new bone formation, thus making the difference between the mean scores of the treatments even smaller with additional time (Table 3). The successful bone formation results achieved in this study with ABM/P-15 are consistent with results obtained in other preclinical models [14][15][16], dental models [17][18][19][20][21][22][23][24][25][26], and the pilot orthopaedic model [9].…”
Section: Discussionsupporting
confidence: 89%
“…Thus, patient satisfaction in lumbar fusions would likely rise if bone graft harvesting could be avoided by using a synthetic agent, like ABM/P-15, that is as effective as autologous bone. P-15 has been shown to be effective in several preclinical models [14][15][16]. A study by Thorwarth et al [15] studied the effectiveness of P-15 in porcine skull defects by creating four different treatment groups: autogenous bone, a porous algae-derived hydroxyapatite (adHA), P-15 and adHA, and P-15 and adHA combined with 25% autogenous bone.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Natural collagen exhibits a unique CD spectrum characterized by a positive peak at around 220 nm, a crossover near 213 nm, and a large negative peak at approximately 197 nm. 48,49 Non-templated (Pro-Hyp-Gly) 10 was used as a stable prototype of a triple helix, while (Pro-ProGly) 3 and calf-skin collagen were used as a negative control and collagen model, respectively. The PT-assembled collagen peptides and CP3 exhibited CD spectra features characteristic of a collagen-like triple helix, including a positive peak around 220-225 nm and a large negative trough near 200 nm ( Figure 2), similar to natural collagen and (Pro-Hyp-Gly) 10 (Figure 2d).…”
Section: Resultsmentioning
confidence: 99%
“…Histological and histomorphometrical results of these studies showed an increase and an acceleration of bone formation when compared to the control sites. This point was also revealed in the study of Thorwarth on the filling of bone cavities created in pig skulls [46]. The filling materials studied separately were the autogenous bone and the two biomaterials used for the present study, PepGen P-15 ® and Osteograph ® N/700.…”
Section: Discussionmentioning
confidence: 96%